The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence

İDİLMAN R., Akyildiz M., Keskin O., Gungor G., Yilmaz T. U., Kalkan C., ...More

CLINICAL TRANSPLANTATION, vol.30, no.10, pp.1216-1221, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 30 Issue: 10
  • Publication Date: 2016
  • Doi Number: 10.1111/ctr.12804
  • Journal Name: CLINICAL TRANSPLANTATION
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1216-1221
  • Keywords: entecavir, hepatitis B immunoglobulin, liver transplantation, tenofovir disoproxil fumarate, LIVER-TRANSPLANT RECIPIENTS, HEPATOCELLULAR-CARCINOMA, SURFACE-ANTIGEN, RISK-FACTORS, PROPHYLAXIS, PREVENTION, IMMUNOPROPHYLAXIS, REINFECTION, LAMIVUDINE, INFECTION
  • Ankara University Affiliated: Yes

Abstract

BackgroundThe aim of this study was to determine the long-term efficacy of nucleos(t)ide analog (NA) and low-dose hepatitis B immunoglobulin (HBIG) combination treatment for preventing post-transplant hepatitis B virus (HBV) recurrence.